Diagnostic methods for primary vitreoretinal lymphoma: A systematic review

• Published in: Survey of ophthalmology 2024-05, Vol.69 (3), p.456-464
• Main Authors: Huang, Ryan S., Mihalache, Andrew, Popovic, Marko M., Cruz-Pimentel, Miguel, Pandya, Bhadra U., Muni, Rajeev H., Kertes, Peter J.
• Format: Article
• Language: English
• Subjects: Biomarkers, Tumor; CD79 Antigens - metabolism; Cytology; Cytometry; Diagnosis; Diagnostic Techniques, Ophthalmological; Flow Cytometry; Humans; Interleukin-10; Interleukin-10 - metabolism; Interleukin-6; Interleukin-6 - metabolism; Intraocular Lymphoma - diagnosis; Intraocular Lymphoma - genetics; Intraocular Lymphoma - metabolism; Myeloid Differentiation Factor 88 - genetics; Polymerase chain reaction; Polymerase Chain Reaction - methods; Primary vitreoretinal lymphoma; Retinal Neoplasms - diagnosis; Sensitivity; Vitreous Body - metabolism; Vitreous Body - pathology
• ISSN: 0039-6257; 1879-3304
• DOI: 10.1016/j.survophthal.2023.12.001

Primary vitreoretinal lymphoma is a potentially aggressive intraocular malignancy with poor systemic prognosis and sometimes significant diagnostic delays as it may masquerade as chronic uveitis. Despite the variety of diagnostic techniques, it is unclear which modality is most accurate in the diagnosis of PVRL. A systematic literature search was conducted on Ovid MEDLINE, EMBASE and the Cochrane Controlled Register of Trials for studies published between January, 2000, and June, 2023. Randomized controlled trials (RCTs) reporting on the following diagnostic tools used to diagnose patients with PVRL were included: cytology, flow cytometry, MYD88 L265P mutation, CD79B mutation, interleukin 10/interleukin-6 (IL-10/IL-6) ratio, polymerase chain reaction (PCR) for monoclonal immunoglobulin heavy chain (IgH) and immunoglobulin kappa light chain (IgK) rearrangements, and imaging findings. The aggregated sensitivity of each diagnostic modality was reported and compared using the chi-squared (χ2) test. A total of 662 eyes from 29 retrospective studies reporting on patients diagnosed with PVRL were included. An IL-10/IL-6 ratio greater than 1 had the highest sensitivity (89.39%, n = 278/311 eyes, n = 16 studies) for PVRL, where the sensitivity was not significantly different when only vitreous samples were drawn (88.89%, n = 232/261 eyes, n = 13 studies) compared to aqueous samples (83.33%, n = 20/24, n = 2) (p = 0.42). Flow cytometry of vitreous samples gave a positive result in 66/75 eyes (88.00%, n = 6 studies) with PVRL, and monoclonal IgH rearrangements on PCR gave a positive result in 354/416 eyes (85.10%, n = 20 studies) with PVRL. MYD88 L265P and CD79B mutation analysis performed poorly, yielding a positive result in 63/90 eyes (70.00%, n = 8 studies) with PVRL, and 20/57 eyes (35.09%, n = 4 studies) with PVRL, respectively. Overall, our systematic review found that an IL-10/IL-6 ratio greater or equal to one may provide the highest sensitivity in identifying patients with PVRL. Future studies are needed to employ multiple diagnostic tools to aid in the detection of PVRL and to further establish nuanced guidelines when determining the optimal diagnostic tool to use in diverse patient populations.